Beijing, China

Yaoguang Jin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: Innovations of Yaoguang Jin in Biopharmaceuticals

Introduction

Yaoguang Jin is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative patents. With a total of three patents to his name, Jin's work focuses on developing novel therapeutic solutions.

Latest Patents

Yaoguang Jin's latest patents include groundbreaking advancements in fusion proteins and polypeptide conjugates. One of his notable patents is for fusion proteins of GDF15, which provides polypeptides comprising serum albumin binding single domain antibody and GDF15. This patent also includes pharmaceutical compositions and methods for treating diseases. Another significant patent involves polypeptide conjugates that comprise a GLP-1 receptor agonist and a peptide linker, along with pharmaceutical compositions and methods for their use in treating various diseases.

Career Highlights

Jin is currently associated with Beijing Ql Biopharmaceutical Co., Ltd., where he continues to push the boundaries of biopharmaceutical research. His work has been instrumental in developing new therapeutic strategies that address unmet medical needs.

Collaborations

Yaoguang Jin collaborates with talented professionals in his field, including coworkers Yuanyuan Zhang and Haixia Zou. Their combined expertise enhances the innovative capacity of their projects and contributes to the advancement of biopharmaceuticals.

Conclusion

Yaoguang Jin's contributions to the field of biopharmaceuticals through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for new treatments and innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…